A control group was maintained in the same conditions but fed with the chow without cuprizone
A control group was maintained in the same conditions but fed with the chow without cuprizone. inflammation, oligodendrocyte loss, demyelination and axonal damage. Current MS licensed treatments are immunomodulatory, reducing the number of relapses, but with no effect on the accumulation of disability in progressive MS1. As progressive disability is thought to be secondary to…